INCY

#604
Incyte Genomics Inc
95.55 USD
-0.54%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
95.55
95.55
Year Range
56.13
112.29
Daily Change
-0.54%
Monthly Change
+3.67%
6 month change
+13.24%
Year Change
+66.78%
Previous Close
96.07
Open
95.55
Bid
Ask
Low
95.55
High
95.55
Volume
156
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 19.02 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.41
Price to sales ratio
3.86

Incyte Corporation

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

News